Appendix C: Sources
1. Endocrine Society Clinical Practice Guideline
Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, Rosenthal SM, Safer JD, Tangpricha V, T’Sjoen GG. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism. 2017;102(11):3869–3903.
https://doi.org/10.1210/jc.2017-01658
2. WPATH Standards of Care, Version 8
Coleman E, Radix AE, Bouman WP, et al. Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. International Journal of Transgender Health. 2022;23(sup1):S1–S259.
https://www.tandfonline.com/doi/full/10.1080/26895269.2022.2100644
3. UCSF Gender Affirming Health Program Guidelines
Deutsch MB, ed. Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People. 2nd ed. University of California, San Francisco; 2016.
https://transcare.ucsf.edu/guidelines
4. Breast development
de Blok CJM, Klaver M, Wiepjes CM, Nota NM, Heijboer AC, Fisher AD, Schreiner T, T’Sjoen G, den Heijer M. Breast Development in Transwomen After 1 Year of Cross-Sex Hormone Therapy: Results of a Prospective Multicenter Study. Journal of Clinical Endocrinology & Metabolism. 2018;103(2):532–538.
https://doi.org/10.1210/jc.2017-01927
5. Body composition and fat redistribution
Klaver M, Dekker MJHJ, de Mutsert R, Twisk JWR, den Heijer M. Cross-sex hormone therapy in transgender persons affects total body weight, body fat and lean body mass: a meta-analysis. Andrologia. 2017;49(5).
https://doi.org/10.1111/and.12660
6. Long-term outcomes cohort
Wiepjes CM, Nota NM, de Blok CJM, et al. The Amsterdam Cohort of Gender Dysphoria Study (1972–2015): Trends in Prevalence, Treatment, and Regrets. Journal of Sexual Medicine. 2018;15(4):582–590.
https://doi.org/10.1016/j.jsxm.2018.01.016
7. Why suppression backfires
Wegner DM, Schneider DJ, Carter SR, White TL. Paradoxical Effects of Thought Suppression. Journal of Personality and Social Psychology. 1987;53(1):5–13.
https://doi.org/10.1037/0022-3514.53.1.5
8. Follow-up meta-analysis
Abramowitz JS, Tolin DF, Street GP. Paradoxical effects of thought suppression: a meta-analysis of controlled studies. Clinical Psychology Review. 2001;21(5):683–703.
https://doi.org/10.1016/S0272-7358(00)00057-X
9. Experiential avoidance
Hayes SC, Wilson KG, Gifford EV, Follette VM, Strosahl K. Experiential avoidance and behavioral disorders: A functional dimensional approach to diagnosis and treatment. Journal of Consulting and Clinical Psychology. 1996;64(6):1152–1168.
https://doi.org/10.1037/0022-006X.64.6.1152
10. Types of dissociation
Holmes EA, Brown RJ, Mansell W, Fearon RP, Hunter ECM, Frasquilho F, Oakley DA. Are there two qualitatively distinct forms of dissociation? A review and some clinical implications. Clinical Psychology Review. 2005;25(1):1–23.
https://doi.org/10.1016/j.cpr.2004.08.006
11. Diagnostic definition
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). American Psychiatric Association Publishing; 2022.
https://doi.org/10.1176/appi.books.9780890425787
12. Permanent removal versus permanent reduction
U.S. Food and Drug Administration. Removing Hair Safely. FDA Consumer Health Information.
https://www.fda.gov/consumers/consumer-updates/removing-hair-safely
13. Androgenetic alopecia treatment
American Academy of Dermatology. Hair loss: Diagnosis and treatment.
https://www.aad.org/public/diseases/hair-loss/treatment/diagnosis-treat